The oncogenic role of these two enzymes still needs more research but we believe that, undoubtedly, our discovery of Tdp1/Tdp2 inhibitors can make a good contribution to the development of potential drug cocktails for the treatment of various types of cancer in combination with topoisomerase poisons. Here, TDP2 is linked to cancer.